Targeting the Oncogenic Tyrosine Kinase NPM-ALK in Lymphoma: The Role of Murine Models in Defining Pathogenesis and Treatment Options

Publisher： Bentham Science Publishers

E-ISSN： 1873-5592|7|10|1329-1334

ISSN： 1389-4501

Source： Current Drug Targets, Vol.7, Iss.10, 2006-10, pp. : 1329-1334

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mechanisms of Clinical Resistance to Small Molecule Tyrosine Kinase Inhibitors Targeting Oncogenic Tyrosine Kinases

By Heiko van der Kuip  

American Journal of PharmacoGenomics, Vol. 5, Iss. 2, 2005-01 ,pp. : 101-112

Adis International

Access to resources Recommend Favorite

Role of the Receptor Tyrosine Kinase Axl and its Targeting in Cancer Cells

By  

Current Medicinal Chemistry, Vol. 23, Iss. 15, 2016-05 ,pp. : 1496-1512

Bentham Science Publishers

Access to resources Recommend Favorite

The Role of the Tyrosine Kinase Inhibitor STI571 in the Treatment of Cancer

By  

Current Cancer Drug Targets, Vol. 1, Iss. 1, 2001-05 ,pp. : 49-57

Bentham Science Publishers

Access to resources Recommend Favorite

Developing Target Therapy Against Oncogenic Tyrosine Kinase in Myeloid Maliganacies

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 5, 2006-10 ,pp. : 331-337

Bentham Science Publishers

Access to resources Recommend Favorite

Proteomics Approaches to Elucidate Oncogenic Tyrosine Kinase Signalingin Myeloid Malignancies

By  

Current Pharmaceutical Biotechnology, Vol. 7, Iss. 3, 2006-06 ,pp. : 185-198

Bentham Science Publishers

Access to resources Recommend Favorite